Provided by Tiger Trade Technology Pte. Ltd.

AbbVie

264.96
+3.131.20%
Post-market: 266.401.44+0.54%19:59 EDT
Volume:5.16M
Turnover:1.37B
Market Cap:468.29B
PE:74.85
High:266.84
Open:260.70
Low:260.10
Close:261.83
52wk High:267.47
52wk Low:190.75
Shares:1.77B
Float Shares:1.76B
Volume Ratio:1.05
T/O Rate:0.29%
Dividend:6.83
Dividend Rate:2.58%
EPS(TTM):3.54
EPS(LYR):2.36
ROE:6225.00%
ROA:10.51%
PB:-78.90
PE(LYR):112.27

Loading ...

AbbVie is Maintained at Outperform by Evercore ISI Group

Dow Jones
·
Aug 11

Vertex Pharmaceuticals Inc Stock (VRTX) Opened Up by 9.76% on Aug 10: What Investors Need To Know

TradingKey
·
Aug 10

Global Drugmakers Invest Billions to Boost US Presence

Reuters
·
Aug 10

Apogee Net Loss Widens to $85.85 Million in Q2 FY26; R&D Expenses Rise to $67.3 Million

Reuters
·
Aug 10

AbbVie Targets Obesity Market With New Phase 2 ABBV-295 Trial

TIPRANKS
·
Aug 08

Nxera Pharma Swings to FY26 H1 Net Profit of JPY 1.59 Billion; Revenue Rises to JPY 18.91 Billion

Reuters
·
Aug 07

Solid Biosciences Q2 Net Loss Widens on Higher R&D Costs

Reuters
·
Aug 07

Aldeyra Net Loss Narrows 44.2% to $5.45 Million in Q2 2026

Reuters
·
Aug 07

Verastem Q2 Revenue Jumps on New Product Sales and Milestone

Reuters
·
Aug 07

Sarepta Faces Competitive Pressures Despite Pipeline Updates, RBC Says

MT Newswires Live
·
Aug 07

Regenxbio Q2 Revenue Surges on AbbVie Milestone Payment

Reuters
·
Aug 06

Regenxbio Q2 FY26 Swings to Net Income of $22.71 Million; Revenue Climbs to $108.02 Million

Reuters
·
Aug 06

AbbVie (ABBV) Gets a Buy from Berenberg Bank

TIPRANKS
·
Aug 06

AbbVie Prices USD 10 Billion Multi-Tranche Senior Notes Offering

Reuters
·
Aug 06

Leerink Partners Adjusts Price Target on AbbVie to $279 From $245

MT Newswires Live
·
Aug 05

Is AbbVie’s (ABBV) BOTOX Masseter Bet Quietly Rewriting Its Post-Humira Growth Story?

Simply Wall St.
·
Aug 05

Wall Street Warms to Healthcare Stocks as Tech Trade Faces Turbulence

Reuters
·
Aug 05

AbbVie upgraded to Buy from Hold at Erste Group

TIPRANKS
·
Aug 05

Abbvie : Leerink Partners Raises Target Price to $279 from $245

THOMSON REUTERS
·
Aug 05

Abbvie: Files for Nine-Part Notes of up to $10.0 Billion - SEC Filing

THOMSON REUTERS
·
Aug 05